1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with autologous (Auto) and allogeneic (Allo) stem cell transplantation (SCT) for relapsed/refractory follicular lymphoma (FL) in the post-rituximab era: A comparative analysis from the National Comprehensive Cancer Network (NCCN) non-Hodgkin's lymphoma (NHL) outcomes database project
    Meeting Abstract

    Evens, A. M.; Vanderplas, A.; LaCasce, A.; Crosby, A.; Nademanee, A.; Kaminski, M. S.; Abel, G. A.; Millenson, M.; Czuczman, M. S.; Rodriguez, M. A.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Innate lymphoid cell-derived IL-22 mediates endogenous thymic repair under the control of IL-23
    Meeting Abstract

    Dudakov, J. A.; Hanash, A. M.; Young, L. F.; Singer, N. V.; West, M. L.; Jenq, R. R.; Smith, O. M.; Holland, A. M.; Boyd, R. L.; van den Brink, M. R. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Late relapses following all-trans retinoic acid for acute promyelocytic leukemia are uncommon, respond well to salvage therapy and occur independently of prognostic factors at diagnosis: Long-term follow-up of North American intergroup study I0129
    Meeting Abstract

    Douer, D.; Zickl, L.; Schiffer, C. A.; Appelbaum, F. R.; Feusner, J. H.; Shepherd, L. E.; Willman, C. L.; Bloomfield, C. D.; Rowe, J. M.; Wiernik, P. H.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Analysis of patients with common peripheral T-cell lymphoma subtypes from a phase 2 study of romidepsin in relapsed or refractory peripheral T-cell lymphoma
    Meeting Abstract

    Coiffier, B.; Pro, B.; Prince, H. M.; Foss, F. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Borchmann, P.; Morschhauser, F.; Wilhelm, M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Enhanced antitumor efficacy of MUC-16 targeted T cells further modified to constitutively express the IL-12 cytokine in a syngeneic model of ovarian cancer
    Meeting Abstract

    Chekmasova, A. A.; Sandadi, S.; Spriggs, D. R.; Brentjens, R. J.
    Blood (2011)

    Fulltext@MSK | Save
  • Tumor-associated macrophages are predictive of survival in relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Casulo, C.; Arcila, M.; Teruya-Feldstein, J.; Maragulia, J.; Moskowitz, C. H.
    Blood (2011)

    Fulltext@MSK | Save
  • Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Meeting Abstract

    Bhagwat, N.; Koppikar, P.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Mullally, A.; Abdel-Wahab, O.; Leung, L.; Weinstein, A.; Marubayashi, S.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Janus kinase-2 inhibition induces durable tolerance to alloantigen by dendritic cell-stimulated human T cells, yet preserves immunity to recall antigen
    Meeting Abstract

    Betts, B. C.; Abdel-Wahab, O.; Curran, S. A.; St Angelo, E. T.; Koppikar, P.; Heller, G.; Levine, R. L.; Young, J. W.
    Blood (2011)

    Fulltext@MSK | Save
  • Validation of a prognostic model and the impact of SF3B1, DNMT3A, and other mutations in 289 genetically characterized lower risk MDS patient samples
    Meeting Abstract

    Bejar, R.; Stevenson, K.; Caughey, B.; Abdel-Wahab, O.; Galili, N.; Garcia-Manero, G.; Kantarjian, H. M.; Raza, A.; Steensma, D. P.; Levine, R. L.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Ex-vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission: A comparison of outcomes in two institutions
    Meeting Abstract

    Bayraktar, U. D.; de Lima, M.; Rima, S. M.; Maloy, M.; Castro-Malaspina, H.; Chen, J. J.; Rondon, G.; Chiattone, A.; Jakubowski, A. A.; Boulad, F.; more...
    Blood (2011)

    Fulltext@MSK | Save